Results 31 to 40 of about 2,987 (146)

Robotic coronary revascularization is feasible and safe: 10-year single-center experience

Heart Views, 2022
Objective: The purpose of this study is to investigate the outcomes of patients undergoing robotic surgical coronary revascularization whether total endoscopic coronary artery bypass (TECAB) or robotic-assisted minimally invasive direct coronary artery ...
Abdul Wahid Al-Mulla, Hatem Hemdan Taha Sarhan, Tamer Abdalghafoor, Sara Al-Balushi, Mohamed Ibrahim El Kahlout, Laith Tbishat, Dina Fa Alwaheidi, Maurice Maksoud, Amr S Omar, Shady Ashraf, Ali Kindawi   +10 more
doaj   +1 more source

A Comparative Analysis of Short‐Term Outcomes of Off Pump Coronary Artery Bypass Grafting Alone or Simultaneous Cerebral Revascularization: A Single‐Center Retrospective Study

Clinical Cardiology, Volume 49, Issue 6, June 2026.
The final flowchart categorizes subjects into two groups: the control group (n = 60) undergoing OPCABG alone and the combined cardiocerebrovascular revascularization group (n = 57). ABSTRACT Objectives The impact of simultaneous coronary artery bypass grafting (CABG) with cerebral revascularization versus CABG alone on perioperative complications and ...
Bo Li, Qing‐Rui Fang, Bo‐Chen Yao, Qing‐Liang Chen, Jun‐Shan Li, Qiang Wang, Feng Zhao, Dong Wei, Dong‐Yan Yang, Jing Sun, Zhi‐gang Guo   +10 more
wiley   +1 more source

Tunable Bioresorbable Scaffolds With Marine Sulfated Polysaccharides for Small‐Caliber Vascular Grafts: A Multi‐Layered Strategy Combining Electrospinning and 4‐Axis Printing

Advanced Healthcare Materials, Volume 15, Issue 16, 24 April 2026.
A multilayered small‐caliber vascular scaffold combining electrospinning and 4‐axis printing is developed and biofunctionalized with marine sulfated polysaccharides from Holothuria tubulosa. The resulting construct exhibits enhanced hemocompatibility, tunable mechanical properties, and supports endothelial and smooth muscle cell adhesion and ...
Gabriele Obino, Alberto Sensini, Tim ten Brink, Gabriele Nieddu, Tristan Bodet, Giovanni Andrea Deiana, Martijn van Griensven, Marilena Formato, Antonio J. Lepedda, Lorenzo Moroni   +9 more
wiley   +1 more source

Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips

Advanced Biology, Volume 10, Issue 2, February 2026.
Buck and Bugter et al. explore the architectural diversity and physiological functions of human barrier systems and reveal how organ‐on‐chip platforms, particularly those integrating patient‐derived cells, are advancing barrier disease modeling. They highlight how emerging biological and technological advances can be used to bridge the gap between ...
Franziska Buck, Jeroen Bugter, Gizem Yorukoglu, Mina Kazemzadeh Dastjerd, Thomas E. Winkler   +4 more
wiley   +1 more source

Programmable Compliance in Small‐Diameter Vascular Grafts by Design of Melt‐Electrowritten Scaffold Architectures for In Situ Tissue Engineering

Advanced Healthcare Materials, Volume 15, Issue 2, 14 January 2026.
Small‐diameter vascular grafts with compliance tunable by design are fabricated via melt electrowriting. By controlling the winding angle of intertwined helical fibers, grafts with compliances matching those of human vessels, from veins to arteries, are realized. This holds the potential of avoiding a compliance mismatch, which has been identified as a
Kilian Maria Arthur Mueller, Christina Ahrens, Linda Grefen, Salma Mansi, Dario Arcuti, Elena De‐Juan‐Pardo, Felix Kur, Christian Hagl, Petra Mela   +8 more
wiley   +1 more source

Epidural Anesthesia as a Protective Factor in Cardiac Surgery: A Prospective Randomized Study

Anesthesiology Research and Practice, Volume 2026, Issue 1, 2026.
Background Epidural anesthesia (EA) has gained prominence in rapid postoperative recovery protocols for cardiac surgery, aiming to reduce opioid use, shorten intensive care stays, and improve patient outcomes. This prospective randomized controlled trial evaluated the protective effects of EA combined with general anesthesia (GA + EA) compared to GA ...
Diego Nicolas Sanchez, Emiliano Raúl Diez, Nicolas Federico Renna, Fabrizio Monaco   +3 more
wiley   +1 more source

Postoperative Atrial Fibrillation Impacted by Completeness of Coronary Revascularization and Antiplatelet Regimen

Cardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Objectives Postoperative atrial fibrillation (POAF) is a common complication after off‐pump coronary artery bypass grafting (OPCABG) and contributes to increased morbidity and prolonged hospital stays. Both myocardial ischemia and systemic inflammation play a critical role in its pathogenesis, which is closely related to the intensity of coronary ...
Qin Jiang, Minghui Xie, Yalu Yu, Zhiai Tang, Jiaqi Xia, Shengshou Hu, Baohui Xu   +6 more
wiley   +1 more source

Contained Rupture of a Saphenous Vein Graft Pseudoaneurysm Following Coronary Artery Bypass Grafting

Case Reports in Cardiology, Volume 2026, Issue 1, 2026.
Saphenous vein graft (SVG) pseudoaneurysms are a rare cause of late graft failure with potentially lethal consequences if left untreated. We present the case of a patient who underwent multivessel coronary artery bypass grafting more than 10 years earlier and presented with chest pain.
Harry Ramcharran, Mahbub Jamil, Joseph Petro, Zhandong Zhou, Satabdi Datta Choudhury   +4 more
wiley   +1 more source

The Evolution of Minimally Invasive Cardiac Surgery Literature: A 50‐Year North American Bibliometric Review and Future Trends

Journal of Cardiac Surgery, Volume 2026, Issue 1, 2026.
Objective This study provides the first bibliometric analysis of minimally invasive cardiac surgery (MICS) in North America, mapping its evolution, collaboration networks, and research trends while forecasting future scientific trajectories through 2050.
Samir Cubas W., Ace Alfabeto, Yasuhiko Kawaguchi, Lin-Rui Guo, Michael W. A. Chu, Irfan Ahmad   +5 more
wiley   +1 more source

Impact of Clopidogrel Treatment on Timing of Coronary Artery Bypass Graft Surgery

Journal of Cardiac Surgery, Volume 2026, Issue 1, 2026.
Objectives Current guidelines advise stopping clopidogrel at least 5 days prior to coronary artery bypass grafting (CABG) in patients with acute coronary syndrome to lower bleeding risk. However, this delay may increase the risk of cardiovascular events. This study evaluated the impact of clopidogrel discontinuation timing on bleeding and postoperative
Tom Friedman, Elad Yosef, Ela L. A. Walling, Maged Makhoul, Roi Glam, Moshe David Campisi Pinto, Gil Bolotin, Frederico Benetti   +7 more
wiley   +1 more source